Alvotech Sa share price logo

Alvotech Sa Share Price

NASDAQ: ALVO

Mid Cap

$5.04

-2.61

(-34.10%)

Live

as on

Alvotech Sa Stock Performance

as on November 3, 2025 at 11:41 pm IST

  • Day's Low

    Day's High

    $5.01
    $5.86
    downward going graph

    0.60%

    Downside

    16.27%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.35
    $13.7
    downward going graph

    -45.83%

    Downside

    171.83%

    Upside

    downward going graph

Alvotech Sa share price movements today

Previous Close
$7.65
Open
$5.81
Volume
3.0M
Day's Low - High
$5.01 - $5.86
52 Week Low - High
$7.35 - $13.7

Alvotech Sa Historical Returns

1 Month Return
-8.05 %
3 Month Return
-12.97 %
1 Year Return
-41.24 %
3 Year Return
+ 25.82 %
5 Year Return
0 %

Alvotech Sa Stock Fundamentals & Key Indicators

Check Alvotech Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

0.3502

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.58%

PE Ratio (TTM)

33.26

Industry PE ratio

8.355964912280701

PEG Ratio

0

EBITDA

74.8M

Revenue (TTM)

562.5M

Profit Margin

11.26%

Return On Equity TTM

0.00%

Alvotech Sa Stock Valuation

Track how Alvotech Sa P/E has moved over time to understand its valuation trends.

Alvotech Sa in the last 5 years

  • Overview

  • Trends

Lowest (-134.80x)

March 31, 2025

Industry (8.36x)

November 3, 2025

Today (33.26x)

November 3, 2025

Highest (60.89x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 33.26x

Alvotech Sa vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alvotech Sa with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Alvotech Sa image
Alvotech Sa
BUY$2.4BNA33.2611.26%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$19.2BNA16.8940.65%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$41.3BNA21.0713.81%
Neurocrine Biosciences Inc. image
Neurocrine Biosciences Inc.
BUY$14.3B49.38%34.115.95%
Zoetis Inc. image
Zoetis Inc.
BUY$63.9B-11.68%24.827.83%

Stock Returns calculator for Alvotech Sa Stock including INR - Dollar returns

The Alvotech Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Alvotech Sa investment value today

Current value as on today

₹44,411

Returns

₹55,589

(-55.59%)

Returns from Alvotech Sa Stock

₹61,290 (-61.29%)

Dollar Returns*

₹5,701 (+5.7%)

Analyst Recommendation on Alvotech Sa Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Alvotech Sa. Average target price of $17.5

Alvotech Sa Share Price Target

Get share price movements and forecasts by analysts on Alvotech Sa.

What analysts predicted

71.2%UPSIDE

Target Price

$17.5

Current Price

$5.04

Analyzed by

11 Analysts

Target

$17.50

Alvotech Sa target price $17.5, a slight upside of 71.2% compared to current price of $5.04. According to 11 analysts rating.

Alvotech Sa Stock’s Investor Sentiment and Interest

Search interest for Alvotech Sa Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-29% versus previous 30 day period

Alvotech Sa Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
15
4
17
53
12
198
102
151
132
173
Gross Profit
-23
-24
-18
-3
-7
153
63
70
67
99
Operating Income
-96
-92
-88
-77
-72
91
12
13
10
18
EBITDA
-91
25
-154
-139
-33
-16
138
-119
137
51
Interest Expense
207
149
49
68
184
42
90
-159
35
33
Depreciation
4
6
6
6
7
7
8
8
8
8
Income Before Tax
-305
168
-205
-308
-225
76
-24
-44
93
9
Income Tax Expense
-29
-20
-17
-32
-6
11
-13
22
-16
-22
Net Income
-276
189
-188
-276
-218
65
-11
-66
109
32
Net Profit Margin
-1740.92%
4311.68%
-1058.63%
-517.99%
-1759.69%
32.82%
-11.07%
-44.29%
82.61%
18.49%

Alvotech Sa Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
31
66
36
83
91
489
Gross Profit
31
66
36
18
-69
304
Operating Income
-61
-137
-235
-346
-354
69
EBITDA
-99
-125
3
-439
-484
-28
Interest Expense
95
97
117
91
134
157
Depreciation
14
16
18
20
24
31
Income Before Tax
-209
-291
-149
-551
-651
-217
Income Tax Expense
0
-121
-47
-38
-99
14
Net Income
-209
-170
-101
-513
-551
-231
Net Profit Margin
-657.55%
-255.26%
-276.04%
-618.55%
-603.42%
-47.35%

Alvotech Sa Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
189
-188
-276
-218
65
-11
-66
109
32
Operating Cash Flow
-41
-117
-67
-75
-50
-71
-39
12
55
Investing Cash Flow
-11
-10
-10
-3
-7
22
-31
-20
-28
Financing Cash Flow
-2
136
20
133
4
155
4
-5
83
Change in Cash
-55
7
-57
53
-53
107
-66
-12
112

Alvotech Sa Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-170
-101
-513
-551
-231
Operating Cash Flow
-74
-228
-312
-312
-236
Investing Cash Flow
-16
-40
-63
-46
-18
Financing Cash Flow
55
254
424
301
297
Change in Cash
-35
-14
48
-55
40

Alvotech Sa News & Key Events

  • img

    Today's Timeline - 22 September

    Mon, 03:50 PM

    -

    European Medicines Agency recommends approval for Alvotech's AVT03 biosimilar to Prolia and Xgeva, pending final decision.

Insights on Alvotech Sa

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 132.76M → 173.23M (in $), with an average increase of 23.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 19.1% return, outperforming this stock by 60.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 67.8% return, outperforming this stock by 42.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ALVO stock has moved down by -13.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 109.68M → 32.03M (in $), with an average decrease of 70.8% per quarter

About Alvotech Sa

alvotech was founded in 2013, with the clear mission to become a global leader in biogenerics, defined as differentiated, high-quality, cost-controlled biosimilars. we have pursued this goal by creating a fully-integrated specialty company in control of every value adding development step from cell line development to commercial manufacturing of the product. our in-house development and manufacturing platform located at four sites across europe drives timely development of a strong and differentiated portfolio, while our state-of-the-art flexible manufacturing facility, located in reykjavik iceland, ensures high quality and cost-effective production. we are passionate about what we have created and our stated purpose of transforming access to life-altering therapies for patients across the globe. we believe in focus and specialization and each of our 250 professionals share our passion and pride to be part of this mission. we are dedicated to making people's lives better by improving a
OrganisationAlvotech Sa
Headquarters9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273
IndustryServices
CEOMr. Vilhelm Robert Wessman
E-voting on sharesClick here to vote

Key Management of Alvotech Sa

Name

Title

Dr. Balaji Venkataramanan Prasad M.D.

Chief Strategy Officer

Mr. Vilhelm Robert Wessman

CEO, Founder & Executive Chairman

Mr. Benedikt Stefansson

VP of Investor Relations and Global Communications

Ms. Tanya Zharov

General Counsel

Ms. Jenny Sif Steingrimsdottir

Vice President of People & Culture

Mr. Anthony M. Maffia III

Chief Regulatory Affairs Officer

Mr. Uri Hillel

Chief Quality Officer

Mr. Johann G Johannsson

Executive Vice President of Capital Markets and M&A

Ms. Linda Jonsdottir

Chief Financial Officer

Mr. Joseph E. McClellan

Chief Scientific & Technical Officer

FAQs

What is Alvotech Sa share price today?

Alvotech Sa share price today is $5.04 as on . Alvotech Sa share today touched a day high of $5.86 and a low of $5.01.

What is the 52 week high and 52 week low for Alvotech Sa share?

Alvotech Sa share touched a 52 week high of $13.7 on and a 52 week low of $7.35 on . Alvotech Sa stock price today i.e. is trending at $5.04,which is 63.21% down from its 52 week high and -31.43% up from its 52 week low.

What is Alvotech Sa's market capitalisation today?

Alvotech Sa market capitalisation is $0.00T as on .

How to invest in Alvotech Sa Stock (ALVO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alvotech Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alvotech Sa Shares that will get you 0.2976 shares as per Alvotech Sa share price of $5.04 per share as on November 3, 2025 at 11:41 pm IST.

What is the minimum amount required to buy Alvotech Sa Stock (ALVO) from India?

Indian investors can start investing in Alvotech Sa (ALVO) shares with as little as ₹88.715 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.15 in Alvotech Sa stock (as per the Rupee-Dollar exchange rate as on ). Based on Alvotech Sa share’s latest price of $5.04 as on November 3, 2025 at 11:41 pm IST, you will get 1.9841 shares of Alvotech Sa. Learn more about fractional shares .